A National Health Insurance System is planned for South Africa. Here are top issues to consider.
Why all the negativity around national health insurance (NHI) in South Africa? There is so much bad news such as comments by the Solidarity Research Institute that NHI will collapse the healthcare system, the Free Market Foundation believes the NHI will be a gateway for corruption, and Alex van den Heever at Wits University thinks […]
Health insurance companies and governments use strong financial and administrative barriers to manage the utilization of new technologies. Cost-sharing (co-insurance or co-payments), prior authorization, clinical panel reviews, therapeutic reference pricing, and new technology appraisals are designed to manage the incremental uptake of new technologies. These technologies, for example, PCSK-9 inhibitors and enzyme replacement therapies, are […]
The market access landscape in the Middle East is changing rapidly. The growth of private health insurance markets in the Gulf is a significant catalyst for the re-organisation of private sector stakeholders and improvements in internal reimbursement policies. In the past, Payors were relatively generous in their reimbursement of new technologies, but in the next […]
There’s so much discussion around Big Data and Real-World Evidence (RWE) in improving access to medicines. RWE is clinical data collected after the publication of clinical trials used for marketing authorization. Sources may include health insurance claims databases, patient registries, hospital patient records, among others. Clinical trials are by design the gold standard for new […]
There’s so much incredible work happening in Africa and the Middle East! Every trip to the region leaves us inspired that access to medicines will continue to improve thanks to skilled and energetic access professionals. These are professionals in pharmaceutical companies, health insurance companies, government institutions, patient organisations, and independent researchers devoted to improving access […]
2017 was an exciting year! As we take a look back at our activities, I’m excited that we completed various projects aimed at strengthening pharmaceutical markets in Africa and the Middle East. In the process, we engaged stakeholders across the spectrum of pharmaceutical markets – government institutions, multilateral agencies, patient organisations, donor agencies, pharma and […]
C&C at ISPOR in Glasgow C&C will be at ISPOR Glasgow in just a few weeks. Will you? We’re presenting results of our recent work for Clients in Sub-Saharan Africa and the Middle East. We put great effort into analysing new health technologies, determining their budget impact in various markets, and assessing market access opportunities. […]